File name: Niosh Hazardous Drug List 2023 Pdf
Rating: 4.9/5 (Based on 4940 votes)
23893 downloads
========================
👉Niosh Hazardous Drug List 2023 Pdf
========================
It also sets forth the process parties can use to request that a drug be added to the list or reconsidered for removal or a different placement on the list. In , NIOSH published . This document provides updated information on the definition, assessment, and control of hazardous drugs in healthcare settings. It includes a table of control approaches for safer . The current official version is the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, The reference site includes 12 additional drugs that have been . NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings (List). This document, Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings, provides information about how the NIOSH List is developed and updated and how reevaluations can be requested. Feb 9, · DHHS (NIOSH) Publication No, (April ) This document lays out the methodology the National Institute for Occupational Safety and Health (NIOSH) uses to determine if a drug meets the criteria for placement on the NIOSH List of Hazardous Drugs in Healthcare Settings. Nov 1, · Specifically, NIOSH considers a drug to be hazardous if it exhibits one or more of the following characteristics in humans or animals: Carcinogenicity; teratogenicity or developmental toxicity; reproductive toxicity; organ toxicity at low doses; genotoxicity; or structure and toxicity profiles of new drugs that mimic existing hazardous drugs. The Procedures document can be used by healthcare facilities to examine new drugs and establish their own lists of hazardous drugs. It also makes clear that NIOSH’s hazardous drugs list is applicable in settings such as veterinary care clinics, drug research laboratories, retail pharmacies, and home healthcare agencies in addition to healthcare. Apr 27, · NIOSH (thus avoiding circular references). Public comment: NIOSH should be differentiating between controls for antineoplastics and other hazardous drugs. NIOSH response: NIOSH reaffirms that this document is intended to apply to all drugs on the List and not just antineoplastics. No change to Managing Exposures has been made in response to. This document provides updated information on the definition, assessment, and control of hazardous drugs in healthcare settings. It includes a table of control approaches for safer handling of hazardous drugs and a list of drugs that meet the NIOSH criteria for hazardous drugs.
